Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 108

Sort by

Sort Order Select

Journal Articles

Frequent genetic alterations in immune checkpoint–related genes in intravascular large B-cell lymphoma

Blood (2021) 137 (11): 1491–1502.

https://doi.org/10.1182/blood.2020007245

Published: 2021

Includes: Supplemental data

Journal Articles

Genomic Analysis of Therapy-Related Myeloid Neoplasms and Tracking of the Founder Clone By Circulating Tumor DNA

Kanya Kondoh, MD, Kazuaki Yokoyama, MD PhD, Nozomi Yusa, Mika Ito, Eigo Shimizu, Sousuke Nakamura, MD, Miho Ogawa, MD, Tomomi Takei, MD, Asako Kobayashi, Rika Kasajima, PhD, Yuka Wada, Rui Yamaguchi, PhD, Seiya Imoto, PhD, Tokiko Nagamura-Inoue, MD PhD, Kaoru Uchimaru, MD, PhD, Satoru Miyano, PhD, Arinobu Tojo, MD PhD

Blood (2019) 134 (Supplement_1): 5393.

https://doi.org/10.1182/blood-2019-127611

Published: 2019

Journal Articles

Loss of Heterozygosity in the Short Tandem Repeat (STR) Loci Found in Tumor DNA of De Novo Diagnosed ALL Patients As a Factor Predicting Poor Outcome

Natalya V Risinskaya, PhD, Olga A. Gavrilina, MD PhD, Julia A. Chabaeva, Anna Yushkova, Andrey B Sudarikov, PhD DSc, Sergei M. Kulikov, PhD, Elena N. Parovichnikova, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2019) 134 (Supplement_1): 5204.

https://doi.org/10.1182/blood-2019-126668

Published: 2019

Journal Articles

Chromosome Banding Analysis Versus Genomic Microarrays: A Comparison of Methods for Genomic Complexity Risk Stratification in Chronic Lymphocytic Leukemia Patients with Complex Karyotype

Blood (2019) 134 (Supplement_1): 4287.

https://doi.org/10.1182/blood-2019-126557

Published: 2019

Journal Articles

An Open-Label Phase I/IIa Study to Evaluate the Safety and Efficacy of CCS1477, a First in Clinic Inhibitor of the p300/CPB Bromodomains, As Monotherapy in Patients with Advanced Haematological Malignancies

Tomasz Knurowski, PhD MD, Karen Clegg, PhD, Nigel Brooks, PhD, Fay Ashby, Neil A Pegg, PhD, William West, PhD, Harriet S Walter, Tim CP Somervaille, MD PhD, Steven Knapper, DM, Andrew Davies, MD PhD

Blood (2019) 134 (Supplement_1): 1266.

https://doi.org/10.1182/blood-2019-124797

Published: 2019

Journal Articles

Circulating Tumor Cells (CTCs) for Comprehensive and Multiregional Non-Invasive Genetic Characterization of Multiple Myeloma (MM)

Blood (2019) 134 (Supplement_1): 3064.

https://doi.org/10.1182/blood-2019-126527

Published: 2019

Journal Articles

Molecular Characterisation of Diffuse Large B Cell Lymphoma in Patients of 80 Years Old or More: Clinical Relevance in a Multicentric Randomized Phase III Study of the Lysa (SENIOR Study)

Blood (2019) 134 (Supplement_1): 2765.

https://doi.org/10.1182/blood-2019-124444

Published: 2019

Journal Articles

Exploring the Potential of Shallow Whole-Genome Sequencing for Diagnosis and Disease Monitoring of Lymphoma in Liquid Biopsy

Lennart Raman, MSc, Malaïka Van Der Linden, MSc, Ciel De Vriendt, Bliede Van Den Broeck, MD, Kristoff Muylle, MD, Dries Deeren, MD PhD, Bjorn Menten, PhD, Fritz Offner, MD, Jo Van Dorpe, MD PhD

Blood (2019) 134 (Supplement_1): 2087.

https://doi.org/10.1182/blood-2019-131391

Published: 2019

Journal Articles

Combination of Phosphodiesterase 4 (PDE4) Inhibitor Roflumilast and R-CHOP As First-Line Therapy for High-Risk Diffuse Large B Cell Lymphoma Patients

Adolfo E Diaz, MD, Matthew James Butler, MD, Anand Karnad, MD, Ricardo Aguiar, MD PhD

Blood (2019) 134 (Supplement_1): 1592.

https://doi.org/10.1182/blood-2019-124382

Published: 2019

Journal Articles

Strategy for Identification of an Inherited Leukemia Predisposition in a 299 Patients Cohort with Tumor-Only Sequencing Data

Almudena Aguilera Díaz, MSc, BS, Sara Palomino-Echeverria, MSc, BSc, Iria Vazquez, PhD BSc, Beñat Ariceta, BSc, Maria Jose Larrayoz, BSc, Amagoia Mañu, BSc, Zuriñe Blasco-Iturri, MSc, BSc, Matxalen Olivares Salaverri, MD, Maria Teresa Olave Rubio, MD, Teresa Bernal Del Castillo, MD PhD, Jose J. Rifon Roca, MD, Ana Alfonso Pierola, MD PhD, Felipe Prosper, MD PhD, Marta Fernández-Mercado, PhD MSc, BSc, Maria Jose Calasanz, PhD BSc

Blood (2019) 134 (Supplement_1): 1415.

https://doi.org/10.1182/blood-2019-126634

Published: 2019

Journal Articles

Detectable Circulating Tumor DNA 28 Days after the CD19 CAR T-Cell Therapy, Axicabtagene Ciloleucel, Is Associated with Poor Outcomes in Patients with Diffuse Large B-Cell Lymphoma

Matthew J. Frank, MD PhD, Nasheed Hossain, MD, Ali Bukhari, MD, Erin Dean, MD, Jay Y. Spiegel, MDFRCPC, Gursharan K. Claire, MPH, Ilan M. Kirsch, Allison P. Jacob, Chelsea D Mullins, BS, Lik Wee Lee, PhD, Katherine A. Kong, Juliana Craig, BA, Crystal L. Mackall, MD, Aaron P. Rapoport, Saurabh Dahiya, MD, Frederick L. Locke, MD, David B Miklos, MD PhD

Blood (2019) 134 (Supplement_1): 884.

https://doi.org/10.1182/blood-2019-132057

Published: 2019

Journal Articles

Yet another susceptibility variant for ALL: what’s next?

Kjeld Schmiegelow

Blood (2019) 133 (7): 628–629.

https://doi.org/10.1182/blood-2018-12-891564

Published: 2019

Journal Articles

Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach

Simona Bernardi, PhD, Camilla Zanaglio, PhD, Elif Dereli Eke, PhDStudent, Federica Cattina, MD PhD, Mirko Farina, MD, Stefania Masneri, PhD, Benedetta Rambaldi, MD, Francesca Schieppati, MD, Alessandro Turra, MD, Nicola Polverelli, MD, Enrico Morello, MD, Michele Malagola, MD, Domenico Russo, MD

Blood (2018) 132 (Supplement 1): 4387.

https://doi.org/10.1182/blood-2018-99-109927

Published: 2018

Journal Articles

Updated Report on Identification of Molecular Predictors of Tazemetostat Response in an Ongoing NHL Phase 2 Study

Blood (2018) 132 (Supplement 1): 4097.

https://doi.org/10.1182/blood-2018-99-115132

Published: 2018

Journal Articles

Monitoring Minimal Residual Disease in Acute Myeloid Leukemia Using Genomic or cfDNA with MyMRD ® , a Targeted NGS Panel

Zhiyi Xie, PhD, Lisa Chamberlain, PhD, Andrew Carson, PhD, Veronika Atkinson, MS, Valerie McClain, MS, James Sprague, Ogeen Kiya, Peng Xia, MS, Wenli Huang, Bradley Patay, MD, Martin Blankfard, Jeffrey E Miller, PhD

Blood (2018) 132 (Supplement 1): 5268.

https://doi.org/10.1182/blood-2018-99-118971

Published: 2018

Journal Articles

Prognostic Impact of Circulating Tumor DNA Status Post-Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Sousuke Nakamura, MD, Kazuaki Yokoyama, MD PhD, Eigo Shimizu, Nozomi Yusa, Miho Ogawa, MD, Tomomi Takei, MD, Asako Kobayashi, Mika Ito, Masamichi Isobe, MD PhD, Takaaki Konuma, MD PhD, Seiko Kato, MD PhD, Rika Kasajima, PhD, Yuka Wada, Tokiko Nagamura-Inoue, MDPhD, Rui Yamaguchi, PhD, Satoshi Takahashi, MD PhD, Seiya Imoto, PhD, Satoru Miyano, PhD, Arinobu Tojo, MD PhD

Blood (2018) 132 (Supplement 1): 247.

https://doi.org/10.1182/blood-2018-99-117938

Published: 2018

Journal Articles

A Next-Generation Sequencing-Based Karyotyping Algorithm Reveals the Genomic Structure of Acute Myeloid Leukemia

Dean Pavlick, Meagan Montesion, PhD, Nyla A. Heerema, PhD, Eric A Severson, MD PhD MMSc, Timothy Brennan, Garrett M Frampton, Jie He, PhD, John C. Byrd, MD, Ross L. Levine, MD, Amy Burd, PhD, Jo-Anne Vergilio, MD, Lee A Albacker, PhD

Blood (2018) 132 (Supplement 1): 2773.

https://doi.org/10.1182/blood-2018-99-116195

Published: 2018

Journal Articles

Whole-Exome and mRNA Sequencing of Multiple Myeloma Reveal Transformation to a More High-Risk and Proliferative Tumor at Relapse

Kristine Misund, PhD, Davine Hofste Op Bruinink, MD, Eivind Coward, PhD, Remco Hoogenboezem, MSc, Even H Rustad, MD, Eivind Hovig, PhD, Anders Sundan, PhD, Ola Myklebost, PhD, Pieter Sonneveld, MD PhD, Anders Waage, MD PhD

Blood (2018) 132 (Supplement 1): 3157.

https://doi.org/10.1182/blood-2018-99-113553

Published: 2018

Journal Articles

Genomic Analysis of Ibrutinib Resistance in Waldenstrom Macroglobulinemia

Cristina Jimenez, PhD, Gloria G Chan, MS, Lian Xu, MS, Nickolas Tsakmaklis, Jiaji G Chen, Maria Demos, Amanda Kofides, Maria Luisa Guerrera, MD, Xia Liu, MD, Manit Munshi, MS, Joshua Gustine, MPH, Guang Yang, PhD, Jorge J. Castillo, MD, Steven P Treon, MD PhD FRCP, Zachary R Hunter, PhD

Blood (2018) 132 (Supplement 1): 1372.

https://doi.org/10.1182/blood-2018-99-118819

Published: 2018

Journal Articles

Integration of Whole Exome and RNA Sequencing Identifies Neoepitope Vaccine Candidates in >90 Percent of Follicular Lymphoma Patients

Cody Ramirez, BS, Kilannin Krysiak, PhD, Felicia Gomez, PhD, Susanna Kiwala, Christopher A. Miller, PhD, Katie Campbell, Jasreet Hundal, Jason Walker, Malachi Griffith, PhD, Obi Griffith, Todd A. Fehniger, MDPhD

Blood (2017) 130 (Supplement 1): 114.

https://doi.org/10.1182/blood.V130.Suppl_1.114.114

Published: 2017

NARROW

Frequent genetic alterations in immune checkpoint–related genes in intravascular large B-cell lymphoma

Genomic Analysis of Therapy-Related Myeloid Neoplasms and Tracking of the Founder Clone By Circulating Tumor DNA

Loss of Heterozygosity in the Short Tandem Repeat (STR) Loci Found in Tumor DNA of De Novo Diagnosed ALL Patients As a Factor Predicting Poor Outcome

Chromosome Banding Analysis Versus Genomic Microarrays: A Comparison of Methods for Genomic Complexity Risk Stratification in Chronic Lymphocytic Leukemia Patients with Complex Karyotype

An Open-Label Phase I/IIa Study to Evaluate the Safety and Efficacy of CCS1477, a First in Clinic Inhibitor of the p300/CPB Bromodomains, As Monotherapy in Patients with Advanced Haematological Malignancies

Circulating Tumor Cells (CTCs) for Comprehensive and Multiregional Non-Invasive Genetic Characterization of Multiple Myeloma (MM)

Molecular Characterisation of Diffuse Large B Cell Lymphoma in Patients of 80 Years Old or More: Clinical Relevance in a Multicentric Randomized Phase III Study of the Lysa (SENIOR Study)

Exploring the Potential of Shallow Whole-Genome Sequencing for Diagnosis and Disease Monitoring of Lymphoma in Liquid Biopsy

Combination of Phosphodiesterase 4 (PDE4) Inhibitor Roflumilast and R-CHOP As First-Line Therapy for High-Risk Diffuse Large B Cell Lymphoma Patients

Strategy for Identification of an Inherited Leukemia Predisposition in a 299 Patients Cohort with Tumor-Only Sequencing Data

Detectable Circulating Tumor DNA 28 Days after the CD19 CAR T-Cell Therapy, Axicabtagene Ciloleucel, Is Associated with Poor Outcomes in Patients with Diffuse Large B-Cell Lymphoma

Yet another susceptibility variant for ALL: what’s next?

Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach

Updated Report on Identification of Molecular Predictors of Tazemetostat Response in an Ongoing NHL Phase 2 Study

Monitoring Minimal Residual Disease in Acute Myeloid Leukemia Using Genomic or cfDNA with MyMRD ® , a Targeted NGS Panel

Prognostic Impact of Circulating Tumor DNA Status Post-Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome

A Next-Generation Sequencing-Based Karyotyping Algorithm Reveals the Genomic Structure of Acute Myeloid Leukemia

Whole-Exome and mRNA Sequencing of Multiple Myeloma Reveal Transformation to a More High-Risk and Proliferative Tumor at Relapse

Genomic Analysis of Ibrutinib Resistance in Waldenstrom Macroglobulinemia

Integration of Whole Exome and RNA Sequencing Identifies Neoepitope Vaccine Candidates in >90 Percent of Follicular Lymphoma Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only